NKGN Insider Trading

Insider Ownership Percentage: 74.65%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

NKGen Biotech Insider Trading History Chart

This chart shows the insider buying and selling history at NKGen Biotech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NKGen Biotech Share Price & Price History

Current Price: $0.43
Price Change: Price Decrease of -0.02 (-4.44%)
As of 02/7/2025 05:00 PM ET

This chart shows the closing price history over time for NKGN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

NKGen Biotech Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/6/2023Paul Y SongCEOBuy75$3.32$249.00171,045View SEC Filing Icon  
11/27/2023Paul Y SongCEOBuy244$2.88$702.72170,701View SEC Filing Icon  
11/21/2023Paul Y SongCEOBuy100$2.80$280.00170,405View SEC Filing Icon  
11/20/2023James A GrafCFOBuy10$2.94$29.4010View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for NKGen Biotech (NYSE:NKGN)

76.17% of NKGen Biotech stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NKGN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

NKGen Biotech Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/7/2025Sequoia Financial Advisors LLC156,000$0.10M0.0%+126.1%0.347%Search for SEC Filing on Google Icon
11/15/2024Polar Asset Management Partners Inc.1,181,872$0.45M0.0%+9.4%3.342%Search for SEC Filing on Google Icon
10/22/2024Sequoia Financial Advisors LLC69,000$26K0.0%+273.0%0.268%Search for SEC Filing on Google Icon
5/1/2024Sequoia Financial Advisors LLC16,000$30K0.0%N/A0.070%Search for SEC Filing on Google Icon
3/14/2024University of Chicago550,000$1.51M2.1%N/A2.513%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
NKGen Biotech logo
NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials. The company was founded in 2017 and is based in Santa Ana, California.
Read More on NKGen Biotech

Today's Range

Now: $0.43
Low: $0.41
High: $0.46

50 Day Range

MA: $0.54
Low: $0.43
High: $0.87

52 Week Range

Now: $0.43
Low: $0.20
High: $4.06

Volume

90,856 shs

Average Volume

164,475 shs

Market Capitalization

$19.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.48

Who are the company insiders with the largest holdings of NKGen Biotech?

NKGen Biotech's top insider shareholders include:
  1. Paul Y Song (CEO)
  2. James A Graf (CFO)
Learn More about top insider investors at NKGen Biotech.

Who are the major institutional investors of NKGen Biotech?

NKGen Biotech's top institutional investors include:
  1. Sequoia Financial Advisors LLC — 0.35%
Learn More about top institutional investors of NKGen Biotech stock.

Which major investors are buying NKGen Biotech stock?

During the previous quarter, NKGN stock was bought by institutional investors including:
  1. Sequoia Financial Advisors LLC
Within the previous year, these company insiders have bought NKGen Biotech stock:
  1. Paul Y Song (CEO)
  2. James A Graf (CFO)
Learn More investors buying NKGen Biotech stock.